IMOPHORON LIMITED

Active Bristol

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IMOPHORON LIMITED

Research and experimental development on biotechnology

Founded 5 Dec 2017 Active Bristol, England 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Sept 2025 Next due 30 Sept 2025 7 months overdue
Confirmation Submitted 10 Dec 2024 Next due 18 Dec 2025 5 months overdue
Net assets £4 £1M 2024 year on year
Total assets £99K £1M 2024 year on year
Total Liabilities £99K £80K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Science Creates Old Market Midland Road Bristol BS2 0JZ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMOPHORON LIMITED (11096893), an active life sciences and medical technology company based in Bristol, England. Incorporated 5 Dec 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

N/A

Net Assets

£4.00

Decreased by £1.07M (-100%)

Total Liabilities

£98.82k

Decreased by £80.46k (-45%)

Turnover

N/A

Employees

9

Decreased by 2 (-18%)

Debt Ratio

100%

Increased by 86 (+614%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 3Oct 2021Seed
Investor 4Oct 2021Seed
Investor 5Oct 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 3,302,729 Shares £5.67m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Dec 2024735,294£250k£0.34
27 Dec 2024735,289£250k£0.34
5 Apr 2023413,711£1.17m£2.82
6 Sept 20211,418,435£4.00m£2.82

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (18)

Octopus Titan Vct Plc
24.9%
Frederic Garzoni
19.3%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Imre Berger

Ceased 6 Sept 2021

Ceased

Frederic Garzoni

Ceased 6 Sept 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Sept 2025GazetteGazette Notice Voluntary
18 Sept 2025AccountsAnnual accounts made up to 2024-12-31
18 Sept 2025DissolutionDissolution Application Strike Off Company
11 Apr 2025OfficersTermination of Meagan Horton as director on 2025-04-11
17 Mar 2025CapitalAllotment of shares (GBP 474.1155) on 2024-12-27
30 Sept 2025 Gazette

Gazette Notice Voluntary

18 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

18 Sept 2025 Dissolution

Dissolution Application Strike Off Company

11 Apr 2025 Officers

Termination of Meagan Horton as director on 2025-04-11

17 Mar 2025 Capital

Allotment of shares (GBP 474.1155) on 2024-12-27

Recent Activity

Latest Activity

Gazette Notice Voluntary

6 months ago on 30 Sept 2025

Annual accounts made up to 2024-12-31

7 months ago on 18 Sept 2025

Dissolution Application Strike Off Company

7 months ago on 18 Sept 2025

Termination of Meagan Horton as director on 2025-04-11

1 years ago on 11 Apr 2025

Allotment of shares (GBP 474.1155) on 2024-12-27

1 years ago on 17 Mar 2025